Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Double congratulations! Well done to both Catherine Garnett and Andrew King who have each been awarded a prestigious Anya Sturdy Fellowship and thank you to the Anya Sturdy Trustees for exceptionally offering to support two fellowships this year. Catherine and Andrew will both take up their fellowships in August, joining the Vyas and Higgs groups respectively. Dr Chris Hatton, Consultant Haematologist who led the interview process was delighted with the appointments and was “confident that the 12 months laboratory experience offered by the fellowship would leave Catherine and Andrew in a good position to submit competitive applications for further clinical training fellowships next year”.

andrew_king_catherine_garnett

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.